| Literature DB >> 30582728 |
Aslinur Ozkaya-Parlakay1, Meltem Polat2, Belgin Gulhan1, Saliha Kanik-Yuksek1, Hasan Tezer1, Selin Nar-Otgun3.
Abstract
Streptococcus pneumoniae causes invasive pneumococcal disease (IPD), leading to high morbidity and mortality worldwide. Although nonvaccine serotypes constitute a major issue in the aspect of invasive pneumococcal disease, serotypes included in PCV13 still continue to be a problem. Vaccination with very high coverage and multicenter surveillance studies would be beneficial to decrease carriage of vaccine and nonvaccine serotypes of pneumococcus and monitor changing seroepidemiology.Entities:
Keywords: invasive pneumococcal disease; pediatric; serotype 3
Mesh:
Substances:
Year: 2019 PMID: 30582728 PMCID: PMC6605843 DOI: 10.1080/21645515.2018.1554975
Source DB: PubMed Journal: Hum Vaccin Immunother ISSN: 2164-5515 Impact factor: 3.452